{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:19:08Z","timestamp":1793726348829,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["61771022, 62071011"],"award-info":[{"award-number":["61771022, 62071011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92315-y","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:31:28Z","timestamp":1741354288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biomarkers of cell cycle arrest, microcirculation dysfunction, and inflammation in the prediction of SA-AKI"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"92315_CR1","doi-asserted-by":"publisher","first-page":"k4891","DOI":"10.1136\/bmj.k4891","volume":"364","author":"JL Poston J T, Koyner J L","year":"2019","unstructured":"Poston J T, Koyner J L. Sepsis associated acute kidney injury. BMJ (Clinical Res. ed). 364, k4891 (2019).","journal-title":"BMJ (Clinical Res. ed)"},{"issue":"6","key":"92315_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","volume":"19","author":"A ZARBOCK","year":"2023","unstructured":"ZARBOCK, A. et al. Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup. Nat. Rev. Nephrol. 19 (6), 401\u2013417 (2023).","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"92315_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"R HOSTE E A, BAGSHAW S M, BELLOMO","year":"2015","unstructured":"Hoste E A, Bagshaw S M, Bellomo R. et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 41 (8), 1411\u20131423 (2015).","journal-title":"Intensive Care Med."},{"key":"92315_CR4","doi-asserted-by":"crossref","unstructured":"Legrand, M. et al. Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials. (2024). Critical care (London, England), 28(1): 92 .","DOI":"10.1186\/s13054-024-04877-4"},{"issue":"9","key":"92315_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00134-023-07138-0","volume":"49","author":"R WHITE K C, SERPA-NETO A, HURFORD","year":"2023","unstructured":"White K C, Serpa-neto A, Hurford R. et al. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med. 49 (9), 1079\u20131089 (2023).","journal-title":"Intensive Care Med."},{"issue":"10","key":"92315_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00134-023-07190-w","volume":"49","author":"D KASUGAI","year":"2023","unstructured":"Kasugai D, Nakashima T, Goto T. Clinical implications of urine output-based sepsis-associated acute kidney injury. Intensive Care Med. 49 (10), 1263\u20131265 (2023).","journal-title":"Intensive Care Med."},{"issue":"9","key":"92315_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00134-023-07171-z","volume":"49","author":"M STANSKI N L, RODRIGUES C E, STRADER","year":"2023","unstructured":"Stanski N L, Rodrigues C E, Strader M. et al. Precision management of acute kidney injury in the intensive care unit: current state of the Art. Intensive Care Med. 49 (9), 1049\u20131061 (2023).","journal-title":"Intensive Care Med."},{"issue":"1","key":"92315_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13613-024-01349-4","volume":"14","author":"L PALMOWSKI","year":"2024","unstructured":"Palmowski, L. et al. Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of Furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7. Ann. Intensiv. Care. 14 (1), 111 (2024).","journal-title":"Ann. Intensiv. Care."},{"key":"92315_CR9","unstructured":"Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. (2013). Critical care (London, England), 17(1): R25 ."},{"issue":"5","key":"92315_CR10","doi-asserted-by":"publisher","first-page":"e2212709","DOI":"10.1001\/jamanetworkopen.2022.12709","volume":"5","author":"L MOLINARI","year":"2022","unstructured":"Molinari, L. et al. Utility of biomarkers for sepsis-associated acute kidney injury staging . JAMA Netw. Open. 5 (5), e2212709 (2022).","journal-title":"JAMA Netw. Open."},{"issue":"9","key":"92315_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.201906-1197OC","volume":"202","author":"M FIORENTINO","year":"2020","unstructured":"Fioentino, M. et al. Serial measurement of cell-cycle arrest biomarkers [TIMP-2] \u00b7 [IGFBP7] and risk for progression to death, dialysis, or severe acute kidney injury in patients with septic shock. Am. J. Respir. Crit Care Med. 202 (9), 1262\u20131270 (2020).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"92315_CR12","doi-asserted-by":"crossref","unstructured":"Rosenbergr C, M. et al. Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis. (2023). Critical care (London, England), 27(1): 234 .","DOI":"10.1186\/s13054-023-04525-3"},{"issue":"10","key":"92315_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00134-024-07586-2","volume":"50","author":"M GIRARDIS","year":"2024","unstructured":"Girardis, M. & Ferrer, D. A. V. I. D. S. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis. Intensive Care Med. 50 (10), 1580\u20131592 (2024).","journal-title":"Intensive Care Med."},{"issue":"8","key":"92315_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M SINGER","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). Jama 315 (8), 801\u2013810 (2016).","journal-title":"Jama"},{"issue":"5","key":"92315_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","volume":"61","author":"PM PALEVSKY","year":"2013","unstructured":"Palevsky, P. M. et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 61 (5), 649\u2013672 (2013).","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"92315_CR16","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.1097\/CCM.0000000000004042","volume":"47","author":"C NUSSHAG","year":"2019","unstructured":"Nussang, C. et al. Cell cycle biomarkers and soluble Urokinase-Type plasminogen activator receptor for the prediction of Sepsis-Induced acute kidney injury requiring renal replacement therapy: A prospective, exploratory study. Crit. Care Med. 47 (12), e999\u2013e1007 (2019).","journal-title":"Crit. Care Med."},{"key":"92315_CR17","doi-asserted-by":"crossref","unstructured":"Hua, T. et al. Megakaryocyte in sepsis: the trinity of coagulation, inflammation and immunity. (2024). Critical care (London, England), 28(1): 442 .","DOI":"10.1186\/s13054-024-05221-6"},{"issue":"2","key":"92315_CR18","doi-asserted-by":"publisher","first-page":"2419523","DOI":"10.1080\/0886022X.2024.2419523","volume":"46","author":"C LIN","year":"2024","unstructured":"Lin, C. et al. Development and validation of an early acute kidney injury risk prediction model for patients with sepsis in emergency departments. Ren. Fail. 46 (2), 2419523 (2024).","journal-title":"Ren. Fail."},{"issue":"6","key":"92315_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01740811","volume":"25","author":"W KARZAI","year":"1997","unstructured":"Karzai, W. et al. Procalcitonin\u2013a new indicator of the systemic response to severe infections. Infection 25 (6), 329\u2013334 (1997).","journal-title":"Infection"},{"issue":"5","key":"92315_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C WACKER","year":"2013","unstructured":"Wacker, C. et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect. Dis. 13 (5), 426\u2013435 (2013).","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"92315_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1159\/000512351","volume":"50","author":"G FU","year":"2021","unstructured":"FU, G. et al. Association between procalcitonin and acute kidney injury in patients with bacterial septic shock. Blood Purif. 50 (6), 790\u2013799 (2021).","journal-title":"Blood Purif."},{"issue":"4","key":"92315_CR22","first-page":"346","volume":"30","author":"X ZHOU","year":"2018","unstructured":"Zhou, X. et al. [Predictive value of inflammatory markers for acute kidney injury in sepsis patients: analysis of 753 cases in 7 years]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 30 (4), 346\u2013350 (2018).","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"3","key":"92315_CR23","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbadis.2018.10.041","volume":"1865","author":"YM LI","year":"2019","unstructured":"Li, Y. M. et al. Downregulation of TIMP2 attenuates sepsis-induced AKI through the NF-\u03bab pathway. Biochim. Et Biophys. Acta Mol. Basis Disease. 1865 (3), 558\u2013569 (2019).","journal-title":"Biochim. Et Biophys. Acta Mol. Basis Disease"},{"issue":"4","key":"92315_CR24","doi-asserted-by":"publisher","first-page":"e22228","DOI":"10.1096\/fj.202101555RR","volume":"36","author":"N JIANG","year":"2022","unstructured":"Jiang, N. et al. TIMP2 mediates endoplasmic reticulum stress contributing to sepsis-induced acute kidney injury. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 36 (4), e22228 (2022).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"issue":"8","key":"92315_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/abbs\/gmz072","volume":"51","author":"X WANG","year":"2019","unstructured":"Wang, X. et al. IGFBP7 regulates sepsis-induced epithelial-mesenchymal transition through ERK1\/2 signaling. Acta Biochim. Biophys. Sin. 51 (8), 799\u2013806 (2019).","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"6","key":"92315_CR26","doi-asserted-by":"publisher","first-page":"e1300","DOI":"10.1038\/cddis.2014.268","volume":"5","author":"VERHAGEN H J","year":"2014","unstructured":"Verhagen H J et al. IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival. Cell Death Dis. 5 (6), e1300 (2014).","journal-title":"Cell Death Dis."},{"key":"92315_CR27","doi-asserted-by":"crossref","unstructured":"Maizel, J. et al. Urinary TIMP2 and IGFBP7 identifies high risk patients of short-term progression from mild and moderate to severe acute kidney injury during septic shock: a prospective cohort study. disease markers, 2019: 3471215. (2019).","DOI":"10.1155\/2019\/3471215"},{"key":"92315_CR28","doi-asserted-by":"crossref","unstructured":"LA A M, Gunning, S. et al. Real-world use of AKI biomarkers: a quality improvement project using urinary tissue inhibitor metalloprotease-2 and insulin-like growth factor binding protein 7 ([TIMP-2]*[IGFBP7]). Am. J. nephrol., 54 (7\u20138): 281\u2009\u2013\u200990. (2023).","DOI":"10.1159\/000531641"},{"issue":"2","key":"92315_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/cc7153","volume":"13","author":"M VAN MEURS","year":"2009","unstructured":"Van Meurs, M. et al. Bench-to-bedside review: angiopoietin signalling in critical illness - a future target?. Crit. Care. 13 (2), 207 (2009).","journal-title":"Crit. Care"},{"issue":"1","key":"92315_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13613-024-01393-0","volume":"14","author":"M ZHUO","year":"2024","unstructured":"Zhuo, M. et al. Angiopoietin-2 as a prognostic biomarker in septic adult patients: a systemic review and meta-analysis. Ann. Intensiv. Care. 14 (1), 169 (2024).","journal-title":"Ann. Intensiv. Care."},{"issue":"3","key":"92315_CR31","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","volume":"3","author":"SM PARIKH","year":"2006","unstructured":"Parikh, S. M. et al. Excess Circulating angiopoietin-2 May contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 3 (3), e46 (2006).","journal-title":"PLoS Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92315-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:31:31Z","timestamp":1741354291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92315-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92315"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92315-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study has been approved by the Ethics Committee of Peking University Third Hospital (M2017032).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"All subjects gave their informed consent to participate in this study for diagnostic and research purposes before inclusion in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval for human experiments"}}],"article-number":"8023"}}